Equities research analysts at William Blair decreased their Q4 2025 earnings estimates for shares of Meta Platforms in a research note issued on Thursday, January 30th. William Blair analyst R.
Research analysts at William Blair increased their FY2026 earnings per share (EPS) estimates for Royal Caribbean Cruises in a report issued on Tuesday, January 28th. William Blair analyst S. Zackfia ...
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq by $4 billion.
Investor's Business Daily on MSN14h
ResMed Tumbles As Organic Sales Growth Steps Down. Will These 'Mega Trends' Save It?ResMed stock tumbled Friday after organic sales growth slowed somewhat in the second fiscal quarter. But one analyst remained upbeat on the "mega trends" driving the CPAP maker.Please watch the video ...
After the Phase II failure of its lead asset from Cerevel, AbbVie is resetting expectations and narrowing the clinical ...
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.
Elon Musk claimed this week that Tesla robotaxi's will hit the roads this summer however skepticism from industry experts and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback